This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Chris Oswald
Founder, Owner, and Principal Consultant at Coswald Consulting LLC
Speaker

Profile

Chris is an independent consultant specializing in CMC related activities. His experience spans from developing oligo related analytical methods in the laboratory, to managing a commercial QC laboratory, and then transitioning into being the manufacturing plant manager for Agilent Technologies. These roles have provided him exposure to many CMC strategies that have been successfully utilized for clinical, pre-commercial, and commercial oligonucleotides in both the drug substance and drug product arenas. Chris also has a wide range of experience in facility buildouts, as well as the successful management of multiple DS and DP CMOs for multiple clients.

Agenda Sessions

  • Workshop Co-Moderators’ Welcome and Opening Remarks

    09:00
  • CMC - Challenges in Upscaling Manufacturing Processes

    09:05